---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-037521"
form_type: "8-K"
ticker: "QNCX"
cik: "0001662774"
company_name: "Quince Therapeutics, Inc."
filed_at: "2024-02-15T23:59:59+00:00"
generated_at: "2026-06-06T01:17:38.487363+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Quince Therapeutics appoints Rajiv Patni as Class III director

## Summary
- Rajiv Patni appointed to board effective Feb 15, 2024 as Class III director, term through 2025 annual meeting.
- Receives $38,000 annual retainer plus 54,000-share stock option grant under 2019 Equity Incentive Plan.
- Options vest in equal annual installments over 3 years, exercise price equals Feb 15 closing price.
- Entered standard indemnification agreement; no family relationships or related party transactions with company.

## SEC filing metadata
- accession: 0001193125-24-037521
- form_type: 8-K
- ticker: QNCX
- cik: 0001662774
- company_name: Quince Therapeutics, Inc.
- filed_at: 2024-02-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1662774/000119312524037521/0001193125-24-037521-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1662774/000119312524037521/d791068d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-037521
- JSON: https://secwatch.observer/filing/0001193125-24-037521.json
- Plain text: https://secwatch.observer/filing/0001193125-24-037521.txt

## Key facts
- Executive change
  Rajiv Patni was appointed as director at Quince Therapeutics, Inc..
  - Action: appointed
  - Role: director
  source text: the board of directors (the “ Board ”) of Quince Therapeutics, Inc. (the “ Company ”) appointed Rajiv Patni to serve as a director of the Company, effective as of February 15, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1662774/000119312524037521/0001193125-24-037521-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.